SK has built a strong network of researchers, policy makers, educators, consultants and employers from all parts of the world to exchange knowledge and experience and discuss current developments and challenges. This directory can be used to help find, support and collaborate with experts from the SK network.

Interested in joining the SK expert directory? Complete the application form. Please check your details in our directory after 48 hrs and if you can not find your name, please contact the directory coordinator at

You can also join the expert directories of our sister organisation: World Association for Sustainable Development (WASD) and Middle Eastern Knowledge Economy Institute (MEKEI).

Photo of Dr. Mohamed Osman

Dr. Mohamed Osman

Senior Researcher, University of York Professor Adjunct, Institute of Endemic Diseases, University of Khartoum


Location: York, UK


I have many years of experience in human vaccine testing, development and research. My works were done in collaborative environment between first class universities and global vaccine manufacturing companies such as GSK and Sanofi. We have now a successful and productive collaboration with the Institute of Endemic, University of Khartoum, under the supervision and directorship of Professor Ahmed Musa. I have established state of art laboratory at the Institute of Endemic diseases, with equipment costs over half a million sterling, a successful venture between University of Khartoum and University of York, that perform cutting edge immunology and molecular biology. This lab will act as a hub for monitoring our vaccine clinical trials, conduction translational research and training students and researchers from Sudan and other countries. I have published in 2017, the first clinical trial of genetic based vaccine against leishmania First in Man. The phase II of the vaccine is now being conducted in Dooka under the umbrella of the Endemic Institute and a dedicated clinical team led by Professor Musa. We have now secure further funding for Sudan to continue on clinical translational research.

Contact expert

subscribe to our newsletter